BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28523493)

  • 1. The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.
    de S B Fróes R; Carvalho ATP; de V Carneiro AJ; de Barros Moreira AMH; Moreira JPL; Luiz RR; de Souza HS
    Eur J Health Econ; 2018 Apr; 19(3):463-470. PubMed ID: 28523493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.
    Mandel MD; Bálint A; Lovász BD; Gulácsi L; Strbák B; Golovics PA; Farkas K; Kürti Z; Szilágyi BK; Mohás A; Molnár T; Lakatos PL
    Eur J Health Econ; 2014 May; 15 Suppl 1():S121-8. PubMed ID: 24832845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B; ;
    J Crohns Colitis; 2014 Jul; 8(7):590-7. PubMed ID: 24351733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil.
    Zaltman C; Parra RS; Sassaki LY; Santana GO; Ferrari MLA; Miszputen SJ; Amarante HMBS; Kaiser Junior RL; Flores C; Catapani WR; Parente JML; Bafutto M; Ramos O; Gonçalves CD; Guimaraes IM; da Rocha JJR; Feitosa MR; Feres O; Saad-Hossne R; Penna FGC; Cunha PFS; Gomes TN; Nones RB; Faria MAG; Parente MPPD; Scotton AS; Caratin RF; Senra J; Chebli JM
    World J Gastroenterol; 2021 Jan; 27(2):208-223. PubMed ID: 33510560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions.
    van der Have M; Fidder HH; Leenders M; Kaptein AA; van der Valk ME; van Bodegraven AA; Dijkstra G; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Oldenburg B; ;
    Inflamm Bowel Dis; 2015 Feb; 21(2):369-77. PubMed ID: 25569738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro.
    de Sá Brito Fróes R; da Luz Moreira A; Carneiro AJV; Moreira JPL; Luiz RR; de Barros Moreira AMH; Monnerat CC; de Souza HSP; Carvalho ATP
    Dig Dis Sci; 2021 Sep; 66(9):2925-2934. PubMed ID: 33044678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
    Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
    World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis.
    Leong RW; Huang T; Ko Y; Jeon A; Chang J; Kohler F; Kariyawasam V
    J Crohns Colitis; 2014 Oct; 8(10):1237-45. PubMed ID: 24662396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease.
    Lima Martins A; Volpato RA; Zago-Gomes MDP
    BMC Gastroenterol; 2018 Jun; 18(1):87. PubMed ID: 29914399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn's disease.
    Stjernman H; Tysk C; Almer S; Ström M; Hjortswang H
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):671-9. PubMed ID: 21654323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.
    Spekhorst LM; Oldenburg B; van Bodegraven AA; de Jong DJ; Imhann F; van der Meulen-de Jong AE; Pierik MJ; van der Woude JC; Dijkstra G; D'Haens G; Löwenberg M; Weersma RK; Festen EAM;
    World J Gastroenterol; 2017 Dec; 23(46):8182-8192. PubMed ID: 29290654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the Quality of Life of Patients Recently Diagnosed with Crohn's Disease and Ulcerative Colitis.
    Bernabéu Juan P; Cabezos Sirvent P; Sempere Robles L; van-der Hofstadt Gomis A; Rodríguez Marín J; van-der Hofstadt Román CJ
    Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
    Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
    J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?
    Ananthakrishnan AN; Beaulieu DB; Ulitsky A; Zadvornova Y; Skaros S; Johnson K; Naik A; Perera L; Issa M; Binion DG; Saeian K
    Inflamm Bowel Dis; 2010 Mar; 16(3):494-500. PubMed ID: 19637332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
    Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
    Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.